Generic name: rabeprazole sodium
Dosage form: capsule, delayed release
Drug class:Proton pump inhibitors
Medically reviewed by Drugs.com. Last updated on Dec 1, 2020.
On This Page
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Drug Interactions
- Use In Specific Populations
- Overdosage
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- Clinical Studies
- How Supplied/Storage and Handling
- Patient Counseling Information
- Medication Guide
Indications and Usage for Rabeprazole Delayed Release Capsules
Rabeprazole sodium delayed-release capsules are indicated for treatment of Gastroesophageal Reflux Disease (GERD) in pediatric patients 1 to 11 years of age for up to 12 weeks.
Rabeprazole Delayed Release Capsules Dosage and Administration
Dosage Regimen
Rabeprazole sodium delayed-release capsules are recommended for up to 12 weeks in pediatric patients 1 to 11 years of age and is dosed by body weight:
- Less than 15 kg: 5 mg once daily with the option to increase to 10 mg once daily, if inadequate response.
- 15 kg or m...
